Viewing Study NCT00227461


Ignite Creation Date: 2025-12-24 @ 1:03 PM
Ignite Modification Date: 2025-12-28 @ 5:33 PM
Study NCT ID: NCT00227461
Status: UNKNOWN
Last Update Posted: 2021-02-17
First Post: 2005-09-26
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Levetiracetam (Keppra) to Improve Chronic Aphasia in Post-stroke Patients.
Sponsor: Kessler Foundation
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module